Abstract: An activation method of a lithium secondary battery includes: (a) preparing a preliminary lithium secondary battery in which the electrode assembly including a positive electrode, a negative electrode, and a separator is housed in a battery case with an electrolyte; (b) initial charging the preliminary lithium secondary battery until the preliminary lithium secondary battery reaches a predetermined voltage; (c) degassing the preliminary lithium secondary battery by removing gases inside the preliminary lithium secondary battery generated during the initial charging and sealing the preliminary lithium secondary battery; and (d) aging the preliminary lithium secondary battery, wherein steps (a) to (d) are performed sequentially.

Abstract: The present invention relates to: a substituted thiazolidinedione derivative compound having a novel structure acting as a sterol regulatory element-binding protein-1 (SREBP1) inhibitor, a hydrate thereof, or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition for preventing or treating cancer, comprising same as an active ingredient.